Original Article
Are herbal medicines alone or in combination for diabetic peripheral neuropathy more effective than methylcobalamin alone? A systematic review and meta-analysis

https://doi.org/10.1016/j.ctcp.2022.101657Get rights and content

Highlights

  • Herbal medicines have been used to treat diabetic peripheral neuropathy (DPN).

  • Seventy-two randomized controlled trials were included in the present study.

  • Herbal medicines revealed a better effect on treating patients with DPN compared to methylcobalamin alone.

  • Herbal medicine and CHM were found to be relatively safe without adverse effects.

  • Further rigorous studies will have to be conducted.

Abstract

Background and purpose

In Asian countries, herbal medicines have been used to treat diabetic peripheral neuropathy (DPN) as an adjunctive therapy. This review aims to assess the effectiveness and safety of herbal medicines for the treatment of DPN.

Methods

A literature search was conducted on PubMed, Embase, CENTRAL, Scopus, CINAHL, CNKI, DBPIA, and OASIS for randomized controlled trials that evaluated the effects of herbal medicines on DPN. The oral methylcobalamin administered group was selected as the control. The primary outcome measure was nerve conduction velocity (NCV), and the secondary outcome measure was the total efficacy rate (TER). The methodological quality of the included studies was assessed using the Cochrane risk of bias tool. A meta-analysis was conducted using Review Manager 5.4.1 software.

Results

Seventy-two RCTs with a total of 6260 patients were included. The meta-analysis showed that herbal medicine and co-administration of herbal medicine and methylcobalamin (CHM) treatment for DPN significantly increased the sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) of the median and common peroneal nerves than methylcobalamin treatment alone. Herbal medicine and CHM treatment for DPN also significantly improved the TER compared to the control group. Herbal medicine and CHM treatment was found to be relatively safe.

Conclusion

Our study suggests that herbal medicine and CHM might be more effective than methylcobalamin alone in the management of DPN. Further rigorous studies should be conducted to make more definite conclusions.

Introduction

Diabetic peripheral neuropathy (DPN) is one of the most common peripheral neuropathic complications of diabetes [1]. The prevalence of DPN varies according to previous studies. In Korea, it is reported that the prevalence of DPN per year in diabetic patients is 20.5–26.6% [2]. Many patients with DPN experience pain, anxiety, depression, and insomnia. This lowers patients’ quality of life and productivity and causes economic losses for both patients and society [3]. In DPN, gradual damage to the nerve fibers affects sensory and motor functions and leads to clinical features such as symmetrical numbness and pain in the limbs [4]. Although controlling the blood sugar level is essential to prevent and slow the progression of DPN, normalization of the blood sugar level through strict dietary control is difficult for most patients. In addition, controlling blood sugar alone may not be effective for DPN that has already occurred [5]. Different medications are available for pain relief. However, there is a lack of evidence on the most effective medication for DPN, and medications cannot treat underlying nerve damage.

As there is a lack of treatment for DPN, which is a major complication of diabetes, studies are actively being conducted to assess the effectiveness and safety of herbal medicines for the treatment of DPN. Previous randomized controlled studies have shown that herbal medicines improve symptoms, nerve conduction velocity, and pain in DPN [6,7]. Additionally, herbal medicines inhibit apoptosis and induce the proliferation of Schwann cells, reduce oxidative stress, and increase the expression of various neurotrophic factors and genes for nerve regeneration in animal models [8,9].

Systematic reviews of the effectiveness of herbal medicines on DPN have been reported. However, there are methodological limitations, such as poor study quality and a small number of samples [[10], [11], [12], [13]]. As many studies have been published, the current study aims to systematically review the literature and meta-analyze the latest studies to verify the effectiveness and safety of herbal medicine for DPN.

Section snippets

Protocol registration

This systematic review and meta-analysis was registered in the Research Registry 2020, with the registration number reviewregistry932. We conducted this study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Statement [14].

Database and search strategy

Studies published until August 31, 2020, were searched in databases including PubMed (MEDLINE), Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, Cumulative Index to Nursing and Allied Health Literature

Study selection

A total of 2455 studies published until August 31, 2020 were retrieved. Among them, 72 studies that satisfied the inclusion criteria were included in this systematic literature review and meta-analysis. Detailed information on the selection process is shown in Fig. 1 according to the PRISMA 2020 statement [14].

Study characteristics

All 72 studies were published in China, with a total of 6260 participants. The most commonly used herbal medicine was Hwanggi Gyeji Omul Tang in 13 studies, followed by Danggui Sayeok

Discussion

This review evaluated effectiveness and safety of herbal medicine on treating diabetic peripheral neuropathy. The main findings were that herbal medicine and CHM treatment could be more effective in improving nerve conduction velocity and general symptom for patients with DPN than methylcobalamin treatment without side effects.

The pathophysiology of DPN is damage to and degeneration of the myelin sheath caused by high blood sugar levels and is related to metabolic, vascular, environmental, and

Conclusion

In conclusion, the use of herbal medicine and CHM in treating patients with DPN has been seen to improve nerve conduction velocity and patients' clinical symptoms. However, it is premature to conclude the effectiveness and safety of herbal medicine and CHM treatment for patients with DPN because of the high clinical heterogeneity and low quality of the included studies. Further rigorous studies should be conducted to confirm these conclusions.

Author contribution statement

Chang-Woo Lee contributed to the conception and design of this study.

Jung-Mi Park supervised the research.

Seung-won Kwon contributed to the development of the methodology.

Chang-Woo Lee and Joon-Soo Jin assessed the risk of bias in the references.

Seung-won Kwon, Chang-Nam Ko, Seong-Uk Park, and Chul Jin performed the statistical analyses.

Chang-Woo Lee wrote the first draft of this manuscript.

Jung-Mi Park, Ki-Ho Cho, Sang-Kwan Moon, Woo-Sang Jung, and Seung-Yeon Cho reviewed the drafts of the

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This manuscript was written based on Chang-Woo Lee's thesis for the Master's degree in Kyung Hee University, 2021.

References (124)

  • Q.L. Wu et al.

    Clinical efficacy observation of diabetic peripheral neuropathy treated with jinmaitong capsules

    World Journal of Integrated Traditional and Western Medicine

    (2012)
  • C.I. Tsai et al.
    (2013)
  • Y. Piao et al.
    (2012)
  • W. Chen et al.

    Topical herbal medicine for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials

    Complementary Medicine Research

    (2011)
  • W. Chen et al.

    Chinese herbal medicine for diabetic peripheral neuropathy

    Cochrane Database Syst. Rev.

    (2013)
  • C.Z. Hao et al.

    Chinese herbal medicine for diabetic peripheral neuropathy: an updated meta-analysis of 10 high-quality randomized controlled studies

    PLoS One

    (2013)
  • M.J. Page et al.

    The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

    Br. Med. J.

    (2021)
  • X.Y. Zheng

    Guideline for Clinical Trials of New Patent Chinese Medicines

    (2002)
  • J.P.T. Higgins et al.

    The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

    Br. Med. J.

    (2011)
  • J.P. Higgins

    Cochrane Handbook for Systematic Reviews of Interventions

    (2011)
  • H.J. Schünemann et al.

    Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

    BMJ

    (2008)
  • M. Egger et al.

    Bias in meta-analysis detected by a simple, graphical test

    Br. Med. J.

    (1997)
  • C. Haiqing et al.

    Clinical observation on 60 cases of diabetic peripheral neuropathy treated by wenshen jianpi decoction [In Chinese]

    Yunnan Journal of Traditional Chinese Medicine

    (2010)
  • C. Xiping

    Clinical observation of 30 cases of diabetic peripheral neuropathy treated with self-made danxie jiangtang huoxue decoction [In Chinese]

    Guiding J Traditional Chinese Med Pharm

    (2010)
  • C. Wen-shi et al.

    Treatment of diabetic peripheral neuropathy by integrated Chinese and western medicine: a clinical observation of 112 cases [In Chinese]

    J Huaihai Med

    (2012)
  • C. Qishao et al.

    Clinical efficacy of diabetic peripheral neuropathy treated with tangbikang tang [In Chinese]

    China Med Pharm

    (2015)
  • C. Yimeng et al.

    Rui zhu tang proved recipe in treatment of diabetes peripheral neuropathy: 60 cases of clinical observation [In Chinese]

    J Ningxia Med College.

    (2015)
  • C. Weini et al.

    Clinical observation of danggui sini decoction in treating diabetic peripheral neuropathy [In Chinese]

    J. New. Chinese. Med.

    (2016)
  • C. Jie

    Clinical Observation on the Treatment of Yi Qi Tong Luo Tang of Diabetic Peripheral Neuropathy with Qi Deficiency and Blood Stasis

    (2017)
  • C. Yanle et al.

    Clinical study of huangqi guizhi wuwu decoction and danggui sini decoction in the treatment of diabetic peripheral neuropathy [In Chinese]

    J China Prescription Drug.

    (2018)
  • C. Zhuanxin

    Clinical study on danggui sini tang combined with mecobalamin tablets for diabetic peripheral neuropathy of blood stasis due to congealing cold type [In Chinese]

    J. New. Chinese. Med.

    (2019)
  • C. Ling et al.

    Modified danggui sini decoction for the treatment of 62 cases of diabetic peripheral neuropathy of cold coagulation and blood stasis [In Chinese]

    Zhejiang J Traditional Chinese Med.

    (2019)
  • C. Yan

    Clinical Observation of Shenqi Decoction Combined with Danggui Sini Decoction in Treating Yang Deficiency and Cold Coagulation Syndrome of Diabetic Peripheral Neuropathy

    (2020)
  • C. Zhong et al.

    Observation of curative effect of yiqi yangyin huoxue decoction in the treatment of diabetic peripheral neuropathy [In Chinese]

    J Modern Medicine and Health

    (2007)
  • D. Wei et al.

    Clinical study of cold congealing and blood stasis type diabetic peripheral neuropathy treating by danggui sini decoction [In Chinese]

    J. Liaoning University Traditional Chinese

    (2016)
  • D. Tian

    The Observation of Clinical Effect of the Qi Deficiency and Blood Stasis Type Diabetic Peripheral Neuropathy Treating by Qi and Blood Circulation Meridians Method

    (2019)
  • F. Zongbao et al.

    Clinical observation of yishen huoxue decoction combined with mecobalamin in the treatment of diabetic peripheral neuropathy [In Chinese]

    Yunnan J Traditional Chinese Medicine and Materia Medica

    (2019)
  • G. Su et al.

    Clinical study on the treatment of 50 cases of diabetic peripheral neuropathy with shengmai powder combined with basic therapy [In Chinese]

    Jiangsu J Traditional Chinese Med

    (2019)
  • G. Youming et al.

    Clinical effects of modified aconiti decoction for diabetic peripheral neuropathy and its influences on the glucose level [In Chinese]

    J Clinical Med in Practice

    (2013)
  • G. Xiaojie

    Clinical research on treating diabetic peripheral neuropathy with the yiqi huoxue tongluo decoction [In Chinese]

    Clinical J Chinese Med

    (2018)
  • H. Hanan

    Study on the therapeutic effect of danggui sini decoction on diabetic peripheral neuropathy [In Chinese]

    Diabetes New World

    (2018)
  • H. Xiaorong et al.

    Clinical study on the treatment of diabetic peripheral neuropathy with xuefu zhuyu decoction

    Sichuan Traditional Chinese Medicine [In Chinese]

    (2005)
  • H. Yue et al.

    Clinical observation of modified jiajian huangqi guizhi wuwu decoction in treating diabetic peripheral neuropathy patients with qi deficiency and blood stasis type [In Chinese]

    Clinical Journal of Traditional Chinese Medicine

    (2018)
  • H. Jia-ming et al.

    Effect of yiqi huoxue tongmai decoction combined with mecobalamin on type 2 diabetic peripheral neuropathy [In Chinese]

    Journal of Taishan Medical College

    (2018)
  • J. Hai-feng et al.

    Observation of tongbihuoxue decoction on diabetic peripheral neuropathy [In Chinese]

    J. Emerg. Tradit. Chin. Med.

    (2013)
  • J. Tingting

    Clinical Observation of Tianqitongluo Decoction in Interfering Diabetes Peripheral Neuropathy of Deficiency of Phelgm and Blood Stasis

    (2013)
  • L. Linli

    Effect of huangqi guizhi wuwu decoction on adjuvant treatment of diabetic peripheral neuropathy and its influence on nerve conduction velocity [In Chinese]

    Nei Mongol Journal of Traditional Chinese Medicine

    (2020)
  • L. Shaoxuan

    Clinical observation of self-made runku soluo decoction in treating diabetic peripheral neuropathy [In Chinese]

    Journal of Clinical and Experimental Medicine

    (2009)
  • L. Yan et al.

    Combination of traditional Chinese medicine and mecobalamin for treatment of diabetic peripheral neuropathy [In Chinese]

    Journal of HeBei United University Health Sciences

    (2015)
  • L. Tingting

    Clinical Observation of Therapeutic Effect Quyidifang on DPN and its Influence on Serum IGF-1

    (2017)
  • 1

    These authors were equally contributed to this manuscript.

    View full text